West Pharma (WST) Misses Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. BMY
8. FIX
9. TSCO
10. BE

Go back to West Pharma (WST) Misses Q4 EPS by 2c

West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend

February 16, 2017 7:01 AM EST

EXTON, Pa., Feb. 16, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed financial guidance for full-year 2017. 

Executive Summary

Fourth-quarter 2016 reported net sales of $382.3 million grew 6.3% over the prior-year quarter.  At constant currency, organic sales growth was 7.7%. Full-year 2016 reported net sales of $1.509 billion grew 7.8% over the prior year.  At constant currency, organic sales growth was 9.1%. Fourth-quarter 2016 reported diluted EPS was $0.52 as compared to $0.45 in the prior-year... More